scholarly article | Q13442814 |
P2093 | author name string | Brian J Druker | |
Robert M Bennett | |||
Kim D Jones | |||
Lisa J Wood | |||
Rachel L Ward | |||
Rebecca L Ross | |||
P2860 | cites work | Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity | Q73320092 |
Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia | Q73523716 | ||
[Fibromyalgia--an update] | Q74414584 | ||
A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise | Q80094846 | ||
IL-1 beta signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2 | Q81297905 | ||
Circulating cytokine levels compared to pain in patients with fibromyalgia -- a prospective longitudinal study over 6 months | Q81403669 | ||
Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents | Q21195680 | ||
Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans | Q24651495 | ||
Chronic stress and age-related increases in the proinflammatory cytokine IL-6 | Q24678400 | ||
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee | Q29618782 | ||
Adult growth hormone deficiency in patients with fibromyalgia | Q33960314 | ||
Growth hormone perturbations in fibromyalgia: a review | Q34001951 | ||
The fibromyalgia impact questionnaire: development and validation | Q34012995 | ||
Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia | Q34064889 | ||
Cytokine-induced sickness behaviour: mechanisms and implications | Q34114821 | ||
Impact of a competitive marathon race on systemic cytokine and neutrophil responses | Q34175333 | ||
Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen | Q34440624 | ||
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline | Q34517215 | ||
Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness | Q34735332 | ||
Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity | Q34735622 | ||
Post-traumatic stress disorder: advances in psychoneuroimmunology | Q34756860 | ||
Systemic inflammatory response to exhaustive exercise. Cytokine kinetics | Q35105353 | ||
Chronic widespread pain and fibromyalgia: what we know, and what we need to know | Q35172591 | ||
Suppressors of cytokine signalling and regulation of growth hormone action | Q35764006 | ||
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. | Q35908588 | ||
Hypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgia | Q36003369 | ||
Inflammation and the etiology of type 2 diabetes | Q36180883 | ||
Neurobiology of fibromyalgia syndrome. | Q36217659 | ||
The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity | Q36254250 | ||
Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network | Q36649111 | ||
Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome | Q36955343 | ||
Proinflammatory cytokines and sickness behavior in rheumatic diseases | Q37185047 | ||
Inflammatory factors, physical activity, and physical fitness in young people | Q37216778 | ||
Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice. | Q40519619 | ||
Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle | Q41237267 | ||
Depression, stress and immunological activation: the role of cytokines in depressive disorders | Q41705538 | ||
Quality of life of adults with chronic illness: a psychometric study | Q42643608 | ||
Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study | Q43690599 | ||
Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone | Q44062283 | ||
Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome | Q44906295 | ||
Morphologic and mechanical basis of delayed-onset muscle soreness. | Q45997061 | ||
Proinflammatory cytokines mediating burn-injury pain | Q46327681 | ||
Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: a microdialysis study | Q46658118 | ||
A syndrome produced by diverse nocuous agents. 1936. | Q48805633 | ||
Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. | Q50898803 | ||
Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress? | Q51082572 | ||
The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. | Q51984544 | ||
Measurement of quality of life: current state of the art. | Q52289709 | ||
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. | Q53620233 | ||
Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. | Q54590339 | ||
Cytokines and depression in cases with fibromyalgia | Q57849462 | ||
Use of the modified Balke treadmill protocol for determining the aerobic capacity of women with fibromyalgia | Q69152371 | ||
Eccentric exercise-induced injury to rat skeletal muscle | Q71666066 | ||
Assessing depression in fibromyalgia patients | Q72697374 | ||
Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells | Q73280351 | ||
P921 | main subject | fibromyalgia | Q540571 |
P304 | page(s) | 9-18 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | The open immunology journal | Q27722046 |
P1476 | title | Preliminary Evidence of Increased Pain and Elevated Cytokines in Fibromyalgia Patients with Defective Growth Hormone Response to Exercise | |
P478 | volume | 3 |
Q35431543 | A mechanism-based approach to prevention of and therapy for fibromyalgia |
Q37533215 | Are depression, anxiety and poor mental health risk factors for knee pain? A systematic review |
Q92130867 | Association between severity of depressive symptoms and chronic knee pain in Korean adults aged over 50 years: a cross-sectional study using nationally representative data |
Q64054472 | Association of derived patterns of musculoskeletal disorders with psychological problems: a latent class analysis |
Q36633298 | Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides |
Q36739178 | Complementary and alternative exercise for fibromyalgia: a meta-analysis |
Q35968464 | Does aerobic exercise affect the hypothalamic-pituitary-adrenal hormonal response in patients with fibromyalgia syndrome? |
Q64261233 | Does aerobic exercise associated with tryptophan supplementation attenuates hyperalgesia and inflammation in female rats with experimental fibromyalgia? |
Q26786533 | Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: a systematic review |
Q35032344 | Estrogen in cycling rats alters gene expression in the temporomandibular joint, trigeminal ganglia and trigeminal subnucleus caudalis/upper cervical cord junction |
Q36186172 | Fibromyalgia syndrome in need of effective treatments |
Q38601633 | Fibromyalgia: A Critical and Comprehensive Review |
Q36336412 | Lack of Circadian Pattern of Serum TNF-α and IL-6 in Patients with Fibromyalgia Syndrome |
Q39989085 | MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study |
Q92711498 | Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome |
Q50278049 | Mutation in cytochrome b gene of mitochondrial DNA in a family with fibromyalgia is associated with NLRP3-inflammasome activation |
Q34761538 | Myofascial trigger points: spontaneous electrical activity and its consequences for pain induction and propagation |
Q37602813 | NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10. |
Q36618726 | Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells |
Q42560675 | Nordic walking in fibromyalgia: a means of promoting fitness that is easy for busy clinicians to recommend |
Q30447974 | Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? |
Q58792988 | Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: A series of four case reports |
Q35039967 | Preliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgia |
Q34655557 | Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status |
Q38715136 | Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics |
Q34060700 | Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. |
Q89697737 | T Cell Subpopulations in the Physiopathology of Fibromyalgia: Evidence and Perspectives |
Q50607178 | The relationship between the fear-avoidance model of pain and personality traits in fibromyalgia patients. |
Search more.